[Elsevier] Interpretation of long-term survival data from MONARCH 3. Letter to the Editor regarding “Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2– advanced breast cancer: final overall survival results of M...

DrNefario Post time 3 day(s) ago | Show all posts |Read mode
Reward10points

journal:Annals of Oncology

Authors:A.D. Sherry; T.A. Lin; Z.R. McCaw; E.B. Ludmir

Published date:2024-6-

DOI:10.1016/j.annonc.2024.05.543

PDF link:https://www.sciencedirect.com/sc ... 92375342400718X/pdf

Article link:http://dx.doi.org/10.1016/j.annonc.2024.05.543

Article Source:Elsevier BV


Remark:

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
aerazo Post time 3 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    21725

Latest Reply

Return to the list